Search Results - Juan Fortea

Refine Results
  1. 1

    Context matters: the evolving use of biomarkers in Alzheimer's disease care by Juan Fortea

    Published in EBioMedicine (2024-10-01)
    Get full text
    Article


  2. 2

    Sex-related differences in genetically determined Alzheimer’s disease by Laura Del Hoyo Soriano, Laura Del Hoyo Soriano, Olivia Wagemann, Alexandre Bejanin, Alexandre Bejanin, Johannes Levin, Johannes Levin, Johannes Levin, Juan Fortea, Juan Fortea, Juan Fortea

    Published in Frontiers in Aging Neuroscience (2025-03-01)
    Get full text
    Article


  3. 3

    Raising awareness and addressing inequities for people with Down syndrome in South Africa by Eimear McGlinchey, Juan Fortea, Bulela Vava, Yvette Andrews, Kirti Ranchod, Atholl Kleinhans

    Published in International Journal for Equity in Health (2025-01-01)
    Get full text
    Article


  4. 4

    Atypical Creutzfeldt-Jakob Disease Evolution after Electroconvulsive Therapy for Catatonic Depression by Iria Grande, Juan Fortea, Ellen Gelpi, Itziar Flamarique, Marc Udina, Jordi Blanch, Raquel Sánchez-Valle

    Published in Case Reports in Psychiatry (2011-01-01)
    Get full text
    Article


  5. 5

    Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome by María Carmona-Iragui, Antoinette O'Connor, Jorge Llibre-Guerra, Patrick Lao, Nicholas J. Ashton, Juan Fortea, Raquel Sánchez-Valle

    Published in EBioMedicine (2024-10-01)
    Get full text
    Article


  6. 6

    Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum by Julie Goossens, Alba Cervantes González, Nele Dewit, Laia Lidón, Juan Fortea, Daniel Alcolea, Alberto Lleó, Olivia Belbin, Eugeen Vanmechelen

    Published in Alzheimer’s Research & Therapy (2023-10-01)
    Get full text
    Article


  7. 7

    Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact by Javier Olazarán, Cristóbal Carnero-Pardo, Juan Fortea, Pascual Sánchez-Juan, Guillermo García-Ribas, Félix Viñuela, Pablo Martínez-Lage, Mercè Boada

    Published in Alzheimer’s Research & Therapy (2023-08-01)
    Get full text
    Article


  8. 8

    DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in D... by Manon Moreau, Maria Carmona-Iragui, Miren Altuna, Lorraine Dalzon, Isabel Barroeta, Marie Vilaire, Sophie Durand, Juan Fortea, Anne-Sophie Rebillat, Nathalie Janel

    Published in Biomedicines (2022-06-01)
    Get full text
    Article


  9. 9

    Insights into the use of biomarkers in clinical trials in Alzheimer's disease by Tharick A. Pascoal, Cristiano S. Aguzzoli, Firoza Z. Lussier, Lucía Crivelli, Claudia K. Suemoto, Juan Fortea, Pedro Rosa-Neto, Eduardo R. Zimmer, Pamela C.L. Ferreira, Bruna Bellaver

    Published in EBioMedicine (2024-10-01)
    Get full text
    Article


  10. 10

    C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease by María-Salud García-Ayllón, Inmaculada Lopez-Font, Claudia P. Boix, Juan Fortea, Raquel Sánchez-Valle, Alberto Lleó, José-Luis Molinuevo, Henrik Zetterberg, Kaj Blennow, Javier Sáez-Valero

    Published in Scientific Reports (2017-05-01)
    Get full text
    Article


  11. 11

    Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum by Anna Rennie, Milan Nemy, Cene Jerele, Iñigo Rodríguez-Baz, Victor Montal, Alexandre Bejanin, Milica G Kramberger, Dag Aarsland, Juan Fortea, Alberto Lleó, Eric Westman, Daniel Alcolea, Daniel Ferreira

    Published in npj Parkinson's Disease (2025-08-01)
    Get full text
    Article


  12. 12

    Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients by Matthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, Elena Camporesi, Gunnar Brinkmalm, Daniel Alcolea, Juan Fortea, Alberto Lleó, Guadalupe Soria, Fernando Aguado, Henrik Zetterberg, Kaj Blennow, Javier Sáez-Valero

    Published in Alzheimer’s Research & Therapy (2022-11-01)
    Get full text
    Article


  13. 13

    Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease by Javier Arranz, Nuole Zhu, Sara Rubio-Guerra, Íñigo Rodríguez-Baz, Rosa Ferrer, María Carmona-Iragui, Isabel Barroeta, Ignacio Illán-Gala, Miguel Santos-Santos, Juan Fortea, Alberto Lleó, Mireia Tondo, Daniel Alcolea

    Published in Alzheimer’s Research & Therapy (2024-06-01)
    Get full text
    Article


  14. 14

    Correction: Diagnostic performance of plasma pTau217, pTau181, Aβ1‑42 and Aβ1‑40 in the LUMIPULSE automated platform for the detection of Alzheimer disease by Javier Arranz, Nuole Zhu, Sara Rubio-Guerra, Íñigo Rodríguez-Baz, Rosa Ferrer, María Carmona-Iragui, Isabel Barroeta, Ignacio Illán-Gala, Miguel Santos-Santos, Juan Fortea, Alberto Lleó, Mireia Tondo, Daniel Alcolea

    Published in Alzheimer’s Research & Therapy (2024-07-01)
    Get full text
    Article


  15. 15

    Cortical macro- and microstructural changes in isolated rapid eye movement sleep behavior disorder by Jèssica Pardo, Ignacio Roura, Victor Montal, Cristina Martín-Barceló, Javier Oltra, Anna Campabadal, Núria Bargalló, Mònica Serradell, Gerard Mayà, Angelica Montini, Carles Gaig, Claustre Pont-Sunyer, Juan Fortea, Alex Iranzo, Carme Junqué, Bàrbara Segura

    Published in npj Parkinson's Disease (2025-07-01)
    Get full text
    Article


  16. 16

    Challenges associated with biomarker‐based classification systems for Alzheimer's disease by Ignacio Illán‐Gala, Jordi Pegueroles, Victor Montal, Eduard Vilaplana, María Carmona‐Iragui, Daniel Alcolea, Bradford C. Dickerson, Raquel Sánchez‐Valle, Mony J. deLeon, Rafael Blesa, Alberto Lleó, Juan Fortea, Alzheimer's Disease Neuroimaging Initiative

    Get full text
    Article


  17. 17

    Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer’s pathophysiological biomarkers by Alba Cervantes González, Julie Goossens, Elena Vera Campuzano, Isabel Sala, M. Belén Sánchez-Saudinós, Íñigo Rodríguez-Baz, Laia Lidón, Danna Perlaza, Alexandre Bejanin, Annakaisa Haapasalo, Juan Fortea, Daniel Alcolea, Alberto Lleó, Eugeen Vanmechelen, Olivia Belbin

    Published in Alzheimer’s Research & Therapy (2025-02-01)
    Get full text
    Article


  18. 18

    Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia by Constance Delaby, Daniel Alcolea, Germain Busto, Audrey Gabelle, Xavier Ayrignac, Karim Bennys, Elena Muiño, Paula Villatoro, Israel Fernández-Cadenas, Nicolas Pradeilles, Shaima El Bounasri, Soraya Torres, Christophe Hirtz, Henrik Zetterberg, Alberto Lleó, Juan Fortea, Sylvain Lehmann

    Published in Alzheimer’s Research & Therapy (2025-02-01)
    Get full text
    Article


  19. 19

    Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid by Geoffroy Gagliardi, Elena Rodriguez-Vieitez, Victor Montal, Jorge Sepulcre, Ibai Diez, Cristina Lois, Bernard Hanseeuw, Aaron P. Schultz, Michael J. Properzi, Kathryn V. Papp, Gad A. Marshall, Juan Fortea, Keith A. Johnson, Reisa A. Sperling, Patrizia Vannini

    Published in Communications Medicine (2023-08-01)
    Get full text
    Article


  20. 20

    Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse by Daniel Alcolea, Jordi Pegueroles, Laia Muñoz, Valle Camacho, Diego López‐Mora, Alejandro Fernández‐León, Nathalie Le Bastard, Els Huyck, Alicia Nadal, Verónica Olmedo, Frederic Sampedro, Victor Montal, Eduard Vilaplana, Jordi Clarimón, Rafael Blesa, Juan Fortea, Alberto Lleó

    Get full text
    Article


Search Tools: